Recent Representations Include:

  • A global, public life-sciences company in connection with parallel DOJ and SEC investigations concerning potential FCPA violations
  • A global, public life-sciences company in connection with a DOJ investigation concerning possible violations of the Anti-Kickback Statute
  • A global, public life-sciences company in connection with a qui tam lawsuit alleging violations of the Anti-Kickback Statute and False Claims Act
  • A global, public life-sciences company in connection with an internal investigation concerning, among other things, clinical data integrity
  • A global, public financial-services company in connection with a SEC investigation concerning possible fraud
  • An executive of a small-cap public company in connection with parallel DOJ and SEC investigations concerning alleged fraud and market manipulation